Apr 8, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Identifying and overcoming solubility challenges continues to be an important issue for pharmaceutical and biotech drug manufacturers. Estimates of 70% of new drugs still suffer from solubility issues. As a result, industry has responded with the development of...
Mar 16, 2020 | All Posts, Controlled Release, Main Blog |
The Next Generation of Drug Delivery: Where Are We Headed? The drug delivery technology market continues to grow rapidly from a technology and application standpoint, particularly in the areas of oral, injectable, topical, nasal, ocular, pulmonary, implantable, and...
Sep 13, 2019 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Oct 3, 2018 | Main Blog |
The drug development model is in need of a drastic shakeup. COVID-19 has only accelerated this. Now more than ever is there a need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic...
Jun 14, 2017 | Main Blog, Peptide |
Having worked with many pharmaceutical and biotech companies over the last few years as the co-organizer of our annual Controlled & Modified Drug Release Summit, the need for many of them to explore opportunities and invest in controlled release technologies...
Recent Comments